According to the company, its Phase 1/2 CLARA trial of AURN001 for corneal edema demonstrated significant dose-dependent ...

Camilla Chong, MD, Chief Medical Officer of InflaRx, commented: "We are pleased to have started our Phase 2a trial for INF904 ...

A controversial legislation submitted by Prime Minister Narendra Modi’s government to change India’s voting system has failed ...

Even as its first tranche of projects begin to really hit their stride, the EU’s Clean Aviation body is preparing the ground for its second phase ... notable change between phases 1 and 2 ...

Viatris Inc. (NASDAQ: VTRS) today announced the publication of Phase 2b CARE study results evaluating the efficacy and safety of cenerimod in adults with moderate-to-severe systemic lupus ...

Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced results from its Phase 2 study of suzetrigine, an investigational, oral, highly selective NaV1.8 pain signal inhibitor in people with ...

Menarini Group announces positive topline data from pivotal phase 3 BROADWAY & TANDEM trials of Obicetrapib and FDC Obicetrapib with Ezetimibe 10 mg: Florence, Italy Wednesday, De ...

The United Kingdom’s Competition and Markets Authority (CMA) will, in the new year, launch a review of its approach to merger ...

This is the last edition of Yield Outlook in 2024. The editorial team wishes our readers a Merry Christmas and a happy and prosperous New Year.

Sangamo Therapeutics, Inc. has groundbreaking treatments for neuropathic pain and Hemophilia A. Click for my updated look at ...